Cargando…

Dihydroartemisinin enhances VEGFR1 expression through up-regulation of ETS-1 transcription factor

Angiogenesis is required for tumor growth. Dihydroartemisinin (DHA), a the effective anti-malarial derivative of artemisinin, demonstrated potent anti-angiogenic activities that closely related to the regulation of vascular endothelial growth factor (VEGF) signaling cascade. VEGF receptor 1 (VEGFR1)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Niu, Na, Yu, Changmei, Li, Liqun, Liu, Qiang, Zhang, Wenqian, Liang, Kaili, Zhu, Youming, Li, Jing, Zhou, Xia, Tang, Jinbao, Liu, Ju
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160690/ https://www.ncbi.nlm.nih.gov/pubmed/30271498 http://dx.doi.org/10.7150/jca.25082

Ejemplares similares

Dihydroartemisinin up‐regulates VE‐cadherin expression in human renal glomerular endothelial cells
por: Li, Liqun, et al.
Publicado: (2017)

Dihydroartemisinin protects blood–brain barrier permeability during sepsis by inhibiting the transcription factor SNAI1
por: Liu, Fuhong, et al.
Publicado: (2022)

Seasonal expressions of VEGF and its receptors VEGFR1 and VEGFR2 in the prostate of the wild ground squirrels (Spermophilus dauricus)
por: Yao, Yuchen, et al.
Publicado: (2021)

Dihydroartemisinin induces endothelial cell anoikis through the activation of the JNK signaling pathway
por: Zhang, Jiao, et al.
Publicado: (2016)

Dihydroartemisinin induces endothelial cell anoikis through the activation of the JNK signaling pathway
por: Zhang, Jiao, et al.
Publicado: (2017)

DOT1L promotes angiogenesis through cooperative regulation of VEGFR2 with ETS-1
por: Duan, Yang, et al.
Publicado: (2016)

Dihydroartemisinin Potentiates VEGFR-TKIs Antitumorigenic Effect on Osteosarcoma by Regulating Loxl2/VEGFA Expression and Lipid Metabolism Pathway
por: Ding, Xiaomin, et al.
Publicado: (2023)

Epithelium-Specific Ets-Like Transcription Factor 1, ESE-1, Regulates ICAM-1 Expression in Cultured Lung Epithelial Cell Lines
por: Yu, Zhiqi, et al.
Publicado: (2015)

Resistance to Dihydroartemisinin
por: Cojean, Sandrine, et al.
Publicado: (2006)

Resistance to Dihydroartemisinin
por: Legrand, Eric, et al.
Publicado: (2007)

Targeting VEGFR1- and VEGFR2-expressing non-tumor cells is essential for esophageal cancer therapy
por: Xu, Wen Wen, et al.
Publicado: (2014)

Mechanisms of Dihydroartemisinin and Dihydroartemisinin/Holotransferrin Cytotoxicity in T-Cell Lymphoma Cells
por: Wang, Qiuyan, et al.
Publicado: (2015)

Dihydroartemisinin as a Sensitizing Agent in Cancer Therapies
por: Li, Qingrong, et al.
Publicado: (2021)

Distinct transcriptional responses of lymphatic endothelial cells to VEGFR-3 and VEGFR-2 stimulation
por: Dieterich, Lothar C., et al.
Publicado: (2017)

Dihydroartemisinin Induces Ferroptosis in HCC by Promoting the Formation of PEBP1/15-LO
por: Su, Ying, et al.
Publicado: (2021)

Dihydroartemisinin inhibits the expression of von Willebrand factor by downregulation of transcription factor ERG in endothelial cells
por: Dong, Fengyun, et al.
Publicado: (2020)

Dihydroartemisinin remodels macrophage into an M1 phenotype via ferroptosis-mediated DNA damage
por: Li, Liu-Gen, et al.
Publicado: (2022)

Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma
por: Jinnin, Masatoshi, et al.
Publicado: (2008)

VEGFR1 and VEGFR2 Involvement in Extracellular Galectin-1- and Galectin-3-Induced Angiogenesis
por: D'Haene, Nicky, et al.
Publicado: (2013)

TUG1/MAZ/FTH1 Axis Attenuates the Antiglioma Effect of Dihydroartemisinin by Inhibiting Ferroptosis
por: Gong, Hailong, et al.
Publicado: (2022)

Dihydroartemisinin inhibits TCTP-dependent metastasis in gallbladder cancer
por: Zhang, Fei, et al.
Publicado: (2017)

Correction to: Dihydroartemisinin inhibits TCTPdependent metastasis in gallbladder cancer
por: Zhang, Fei, et al.
Publicado: (2022)

Anti-malarial drug dihydroartemisinin downregulates the expression levels of CDK1 and CCNB1 in liver cancer
por: Hao, Liyuan, et al.
Publicado: (2021)

Artesunate and Dihydroartemisinin Inhibit Rabies Virus Replication
por: Luo, Jun, et al.
Publicado: (2021)

Effects of dihydroartemisinin on the gut microbiome of mice
por: Liu, Yanyan, et al.
Publicado: (2020)

Interaction between PD-L1 and soluble VEGFR1 in glioblastoma-educated macrophages
por: Liu, Xin, et al.
Publicado: (2023)

Combined Transcriptome and Proteome Profiling for Role of pfEMP1 in Antimalarial Mechanism of Action of Dihydroartemisinin
por: Chen, Lina, et al.
Publicado: (2021)

Blockade of VEGFR-1 and VEGFR-2 Enhances Paclitaxel Sensitivity in Gastric Cancer Cells
por: Hwang, Jun-Eul, et al.
Publicado: (2013)

Diagnostic Value of VEGF-A, VEGFR-1 and VEGFR-2 in Feline Mammary Carcinoma
por: Nascimento, Catarina, et al.
Publicado: (2021)

The transcriptional control of the VEGFA-VEGFR1 (FLT1) axis in alternatively polarized murine and human macrophages
por: Domokos, Apolka, et al.
Publicado: (2023)

The analgesic and antidepressant properties of dihydroartemisinine in the neuropathic pain mice: By the downregulation of HnRNPA1 in the spinal cord and hippocampus
por: Zhu, Chunyan, et al.
Publicado: (2022)

Correction to: Dihydroartemisinin inhibits TCTP-dependent metastasis in gallbladder cancer
por: Zhang, Fei, et al.
Publicado: (2019)

Dihydroartemisinin inhibits endothelial cell migration via the TGF-β1/ALK5/SMAD2 signaling pathway
por: Guo, Ling, et al.
Publicado: (2021)

Dihydroartemisinin Induces Endothelial Cell Autophagy through Suppression of the Akt/mTOR Pathway
por: Liu, Jing, et al.
Publicado: (2019)

The pharmaceutical death-ride of dihydroartemisinin
por: Jansen, Frans Herwig
Publicado: (2010)

Pilot study: bioequivalence of dihydroartemisinin in dihydroartemisinin-piperaquine tablet generic formulation in healthy Indonesian volunteers
por: Isnawati, Ani, et al.
Publicado: (2023)

Pseudopodium-enriched atypical kinase 1 mediates angiogenesis by modulating GATA2-dependent VEGFR2 transcription
por: Wang, Huawei, et al.
Publicado: (2018)

Dihydroartemisinin-induced mitochondrial mRNA degradation and apoptosis in keloid fibroblasts
por: Li, Qijie, et al.
Publicado: (2022)

VEGF-dependent tumor angiogenesis requires the inverse and reciprocal regulation of VEGFR1 and VEGFR2
por: Zhang, Zhaocheng, et al.
Publicado: (2009)

Computational Modeling to Quantify the Contributions of VEGFR1, VEGFR2, and Lateral Inhibition in Sprouting Angiogenesis
por: Kühn, Clemens, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5j2ed2m3cegulqb4bre6rbavfs